Actualités - Publications 2009


Jean-Philippe Lafrance publie dans le Journal Pharmacoepidemiology and Drug Safety :

Selective and non-selective non-steroidal anti-inflammatory drugs and the risk of acute kidney injury.

Mélanie Béland publie dans le journal Molecular Cancer Research :
Calcineurin a-binding protein, a novel modulator of the calcineurin nuclear factor of activated T-cell signaling pathway, is overexpressed in wilms' tumors and promotes cell migration.

Darren Yuen publie dans Hypertension :
The (Pro)Renin Receptor. Site-Specific and Functional Linkage to the Vacuolar H+-ATPase in the Kidney.

Michael Walsh publie dans le journal in Kidney International :
Nocturnal hemodialysis does not improve overall measures of quality of life compared to conventional hemodialysis.

Lakshman Gunaratnam publie dans le Journal of translational medicine :
TRIP-Br2 promotes oncogenesis in nude mice and is frequently overexpressed in multiple human tumors.
 
 
 

The KRESCENT Program is a Strategic Training Program developed and supported by:

                                                    


With additional generous support from:

AMGEN               Baxter Corporation               Merck-Frosst Canada Ltd.             Ortho Biotech              RocheShire BioChem Inc.

© 2005 The Kidney Foundation of Canada